U.S. Biochip Product & Services Market Rapid Growth By top Players Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd

Biochips namely DNA microarray, protein microarray, and microfluidic chip. Increasing number of clinical trials along with technological advancements are expected to aid in growth of the market. Furthermore, increasing product approvals and increasing incidence of chronic diseases is also expected to assist the growth of the market during the forecasted period.

PDF Brochure of This Business Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/3899

U.S. Biochip Products and Services Market: Drivers

Approval and launch of new products is expected to propel growth of the U.S. biochip products and services market over the forecast period. For instance, in April 2019, AYOXXA Biosystems GmbH launched LUNARISTM Chemokine Kits for exploration of human (Human 11-Plex) and murine (Mouse-12-Plex) chemokine signaling pathways.

U.S. Biochip Products and Services Market: Opportunities

R&D in biochips is expected to offer lucrative growth opportunities for players in the U.S. biochip products and services market. For instance, in May 2020, researchers from Russian Academy of Sciences, Russia, reported development of 3D biochips and optimized analytical procedures that can facilitate further studies towards practical application for hepatitis C virus detection.

Market Trends

Integration of biochips with next-generation sequencing. Biochip platforms for single-cell or rare-molecule analyses by next-generation sequencing facilitates convenient preparation of nucleic acids from biological systems.

Increasing development in personalized medicine is expected to aid in growth of the market. Biochips along with next-generation sequencing can be used in drug screening for personalized medicine.

Request For Customization Of This Business Research Report:
https://www.coherentmarketinsights.com/insight/request-customization//3899

Competitive Landscape

Major players operating in the U.S. biochip products and services market include, Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, and AYOXXA Biosystems GmbH.

Key Developments

April 2019: Qurin Diagnostics B.V. and Lionix International B.V. acquired Surfix B.V., a supplier of custom-made nanocoatings

January 2019: AYOXXA Biosystems GmbH signed a research agreement with one of the leading pharmaceutical companies (details were not disclosed) for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology

Detailed Segmentation:

U.S. Biochip Products and Services Market, By Type:
Products
Microarrays
Reagents & other Consumables
Others
Services
U.S. Biochip Products and Services Market, By Application:
Drug Discovery
Life Science Research
IVD Tests
Others

Apply Promo Code “STAYHOME” and Get Up to 30% Discount

Buy This Complete A Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/3899

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.